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INTRODUCTION 
Synthetic scaffolds combined with growth factors have the potential to replace allograft or autograft as a 
graft material for spinal interbody fusion. Such tissue engineering approaches may be useful in 
Adolescent Idiopathic Scoliosis (AIS) surgery, however there are no studies to date examining the use of 
such biodegradable implants in combination with biologics in a thoracic spine model. This in vivo study 
examines the use of biodegradable polycaprolactone (PCL) based scaffolds with rhBMP-2 as a bone 
graft substitute in a sheep thoracic fusion model, where an anterior approach is used to simulate 
minimally invasive surgical deformity correction in the setting of AIS.  
 
METHODS 
14 male Merino sheep aged 4 to 6 years and weighing 45 – 50 kg were divided into two groups and 
evaluation time points; three months (n=7) and six months (n=7) respectively. Three thoracic 
intervertebral spaces (T6/7, T8/9 & T10/11) in each animal were randomly allocated to receive either (i) 
PCL Calcium phosphate (CaP) coated scaffold with rhBMP-2, (ii) CaP coated scaffold alone or (iii) rib 
head autograft. The scaffold design was based on a 0-90 lay-down pattern plus scaffold contour to 
confer additional strength for surgical handling and implantation of the prepared disc space. The 
scaffolds (Figure 1) were fabricated using PCL and a BioExtruder, a computer-controlled extrusion- 
based additive manufacturing device developed at the Polytechnic University of Leiria, Portugal [1]. The 
treated intervertebral disc spaces were stabilized with a 5.5 mm titanium rod secured with two vertebral 
screws. All animal related procedures were approved by the animal ethical review committee. Explanted 
thoracic spinal segments (T4-L1) of all the animals were CT scanned using a high-speed tomography 
scanner (Phillips Brilliance 64) with the following parameters. X-Ray source current and voltage of 
200mA and 120kV respectively, and a 14cm field of view at 0.7 mm slice thickness. Reformatted sagittal, 
coronal and axial images were generated from the CT data using ImageJ software and fusion scores 
were assessed (Glassman [2]). To date, CT fusion grading has been conducted on two sheep sacrificed 




A mean fusion grade of 4.3 was observed at the PCL CaP coated scaffold with rhBMP-2 level with 
attainment of solid unilateral fusion. At the autograft level, grade 4 mean fusion was observed and grade 
1 mean fusion at the scaffold only level.  
 
CONCLUSION 
Preliminary results demonstrate radiologically evident bony fusion at the PCL CaP coated scaffold level 
which is observed to be a similar grade to autograft, while no fusion is seen at the scaffold only level. 
Results to date suggest that the combination of rhBMP-2 and scaffold engineering actively promotes 







     Figure 1. CT scan of a fabricated scaffold 
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